Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ohno

Showing results (281-290 of 400) with videos related to

Pageof 40
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1986
Treatment of leukemia and myelodysplastic syndromes with orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosineR Ohno, M Hirano, K Yamagata, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1990
An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphomaR Ohno, K Okada, T Masaoka, et al.
Leukemia Research|March 14, 2000
Poor clinical significance of p53 gene polymorphism in acute myeloid leukemiaY Nakano, T Naoe, H Kiyoi, et al.
Bone Marrow Transplantation|March 1, 1988
Administration of human urinary colony stimulating factor after bone marrow transplantationT Masaoka, K Motoyoshi, F Takaku, et al.
Leukemia|April 1, 1995
Prognostic significance of the RT-PCR assay of PML-RARA transcripts in acute promyelocytic leukemia. The Leukemia Study Group of the Ministry of Health and Welfare (Kouseisho)H Fukutani, T Naoe, R Ohno, et al.
Leukemia|January 1, 1994
All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in JapanR Ohno, K Ohnishi, A Takeshita, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Treatment of acute leukemia and malignant lymphoma with (2"R)-4'-O-tetrahydropyranyladriamycinR Ohno, K Kimura, I Amaki, et al.
Investigational New Drugs|January 1, 1987
A phase II study of (2"R)-4'-0-tetrahydropyranyladriamycin (THP) in hematological malignanciesK Yamada, S Shirakawa, R Ohno, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1987
Phase I clinical and pharmacokinetic study of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosineR Ohno, K Kimura, K Ota, et al.
Blood|November 1, 1989
Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings; possible role of genetic homogeneity. The Nagoya Bone Marrow Transplantation GroupY Morishima, Y Morishita, M Tanimoto, et al.
Pageof 40

Showing results (281-290 of 400) with videos related to

Sort By:
Pageof 40
Cancer Chemotherapy and Pharmacology|January 1, 1986
Treatment of leukemia and myelodysplastic syndromes with orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosineR Ohno, M Hirano, K Yamagata, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1990
An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphomaR Ohno, K Okada, T Masaoka, et al.
Leukemia Research|March 14, 2000
Poor clinical significance of p53 gene polymorphism in acute myeloid leukemiaY Nakano, T Naoe, H Kiyoi, et al.
Bone Marrow Transplantation|March 1, 1988
Administration of human urinary colony stimulating factor after bone marrow transplantationT Masaoka, K Motoyoshi, F Takaku, et al.
Leukemia|April 1, 1995
Prognostic significance of the RT-PCR assay of PML-RARA transcripts in acute promyelocytic leukemia. The Leukemia Study Group of the Ministry of Health and Welfare (Kouseisho)H Fukutani, T Naoe, R Ohno, et al.
Leukemia|January 1, 1994
All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in JapanR Ohno, K Ohnishi, A Takeshita, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
Treatment of acute leukemia and malignant lymphoma with (2"R)-4'-O-tetrahydropyranyladriamycinR Ohno, K Kimura, I Amaki, et al.
Investigational New Drugs|January 1, 1987
A phase II study of (2"R)-4'-0-tetrahydropyranyladriamycin (THP) in hematological malignanciesK Yamada, S Shirakawa, R Ohno, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1987
Phase I clinical and pharmacokinetic study of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosineR Ohno, K Kimura, K Ota, et al.
Blood|November 1, 1989
Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings; possible role of genetic homogeneity. The Nagoya Bone Marrow Transplantation GroupY Morishima, Y Morishita, M Tanimoto, et al.
Pageof 40